Sensorion
Clinical-stage biotech developing novel therapies for hearing loss, vertigo, and tinnitus.
ALSEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0012596468 (+2 more)
- LEI:
- 969500P0W8XJ9CGZDP97
- Country:
- France
- Address:
- 375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER
- Website:
- https://www.sensorion.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Sensorion is a clinical-stage biotechnology company specializing in the development of novel therapies for inner ear disorders. The company's mission is to address significant unmet medical needs by developing treatments to restore, treat, and prevent hearing loss, vertigo, and tinnitus. Its strategy is structured around three pillars: 'Restore,' which focuses on gene therapies for genetic forms of hearing loss; 'Treat,' which develops small molecule solutions for existing conditions; and 'Prevent,' which aims to protect against non-genetic hearing loss (e.g., drug- or surgery-induced). Sensorion utilizes a unique R&D technology platform to advance its understanding of inner ear disease pathophysiology and collaborates with partners, including the Institut Pasteur, to build its therapeutic pipeline.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sensorion and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-04 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 168.5 KB | |
| 2025-09-04 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 174.1 KB | |
| 2025-08-15 07:30 |
Capital/Financing Update
Inside Information / Other news releases
|
English | 139.2 KB | |
| 2025-08-15 07:30 |
Capital/Financing Update
Informations privilégiées / Autres communiqués
|
French | 140.2 KB | |
| 2025-07-29 07:30 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 188.2 KB | |
| 2025-07-29 07:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 192.0 KB | |
| 2025-07-01 07:30 |
Earnings Release
Inside Information / Other news releases
|
English | 187.9 KB | |
| 2025-07-01 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 194.8 KB | |
| 2025-05-13 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 133.2 KB | |
| 2025-05-13 07:30 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 139.4 KB | |
| 2025-05-06 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 180.6 KB | |
| 2025-05-06 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 176.8 KB | |
| 2025-04-25 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 151.9 KB | |
| 2025-04-25 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 171.2 KB | |
| 2025-04-18 09:24 |
Pre-Annual General Meeting Information
Inside Information / Other news releases
|
English | 163.1 KB |
Automate Your Workflow. Get a real-time feed of all Sensorion filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Sensorion via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-11 | N/A | Other | Other | 2,781,914 | 1,752,605.82 EUR |
| 2024-04-11 | N/A | Other | Other | 1,587,301 | 999,999.63 EUR |
| 2024-02-13 | N/A | Other | Other | 16,842,105 | 9,599,999.85 EUR |
| 2024-02-08 | N/A | Other | Other | 12,280,701 | 6,999,999.57 EUR |
| 2023-08-08 | N/A | Other | Other | 46,428,571 | 12,999,999.88 EUR |
| 2023-08-03 | N/A | Other | Other | 25,000,000 | 7,000,000.00 EUR |
